FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mckesson Megestrol Acetate Oral Suspension Recall

Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 c…

Mckesson Corporation · Memphis, TN

Risk level
Class II
Reported by FDA
Sep 12, 2018
Recall ID
D-1172-2018
Check your lot numberHow we source this data

Summary

Mckesson recalled Megestrol Acetate Oral Suspension starting Aug 14, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1172-2018 on Sep 12, 2018. Reason: Supterpotent Drug. Status: Terminated.

Why it was recalled

Supterpotent Drug

Product description

Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977 Dist. By: McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51

Lot numbers, UPCs & expiration codes

Lot #: 0116158 Exp. 4/30/19; 0113903, 0113902, 0113901, Exp. 8/31/18

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1172-2018
Classification
Class II
Status
Terminated
Recall initiated
Aug 14, 2018
FDA report date
Sep 12, 2018
Quantity
1531 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Mckesson Corporation

Original FDA data

Every field from FDA enforcement report D-1172-2018, exactly as published.

Show all FDA fields
City
Memphis
State
TN
Status
Terminated
Country
United States
Event ID
80830
Address
4836 Southridge Blvd
Code information
Lot #: 0116158 Exp. 4/30/19; 0113903, 0113902, 0113901, Exp. 8/31/18
Postal code
38141-8300
Report date
Sep 12, 2018
Product type
Drugs
Recall number
D-1172-2018
Classification
Class II
Recalling firm
Mckesson Corporation
Product quantity
1531 cartons
Termination date
Nov 25, 2020
Reason for recall
Supterpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977 Dist. By: McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51
Distribution pattern
Nationwide within the United States
Recall initiation date
Aug 14, 2018
Initial firm notification
Letter
Center classification date
Sep 5, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1172-2018, published Sep 12, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls